about us
BridgeBio Pharma Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers, and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn and Twitter.
press releases
presentations
events
stock information
| Change | |
|---|---|
| Volume | |
| Today's Open | |
| Previous Close |
| Today's High | |
|---|---|
| Today's Low | |
| 52 Week High | |
| 52 Week Low |